Tag: raw materials

Justifying Pharmacopoeial Changes Not Implemented During Audit Review In the highly regulated world of pharmaceutical manufacturing, adherence to pharmacopoeial standards is crucial for ensuring product quality and regulatory compliance. However,…

Strategies for Addressing Test Method Non-Compliance in Routine Testing Test method non-compliance during routine testing can lead to serious implications for product quality, regulatory compliance, and ultimately, market access. This…

Addressing Unjustified In-house Specifications During Routine Testing: A Practical Justification Strategy In pharmaceutical manufacturing, the establishment of in-house specifications during routine testing can pose significant compliance and quality challenges. The…

Analysis of Compliance Gaps Related to Outdated Pharmacopoeial Monographs in Pharmaceutical Manufacturing Pharmaceutical manufacturers are often confronted with the challenge of ensuring compliance with current pharmacopoeial standards during inspections. The…

Utilizing Updated Pharmacopoeial Monographs During Audit Reviews: Ensuring Compliance and Preventing Issues In the highly regulated environment of pharmaceutical manufacturing, adherence to current standards is non-negotiable. An outdated pharmacopoeial monograph…

Investigating Unjustified In-House Specifications During Regulatory Audits In the pharmaceutical industry, ensuring that specifications align with regulatory standards is vital for maintaining compliance and product quality. An unjustified in-house specification…

CAPA Investigation for Unimplemented Pharmacopoeial Changes During Submission Support In the pharmaceutical manufacturing landscape, compliance with pharmacopoeial standards is crucial to ensure the quality and safety of products. A failure…

Addressing the Risks of Non-Compliance with Pharmacopoeial Changes During Supplier Qualification In today’s intricate pharmaceutical landscape, ensuring compliance with updated pharmacopoeial standards is crucial for maintaining quality and safety in…

Addressing Unjustified In-House Specifications During Audit Reviews to Prevent Recurrence The pharmaceutical industry often faces challenges related to compliance and quality assurance, particularly when it comes to in-house specifications for…

Creating an Inspection-Ready Strategy for Test Method Non-Compliance in Audits In the world of pharmaceutical manufacturing, test method non-compliance during audit reviews poses significant challenges to quality assurance and regulatory…

Misapplication of Reference Standards During Inspection: Developing a CAPA for Compendial Failures The use of reference standards is a critical aspect of pharmaceutical quality control and compliance. However, instances of…

Risks of Using Outdated Pharmacopoeial Monographs During Supplier Qualification In pharmaceutical manufacturing, ensuring the quality and compliance of raw materials is a paramount concern. A common problem that organizations face…